Los Angeles Biotech News

Taking pulse on private biotech funding; Q&A with Isomorphic Labs CEO; Research institutions rethinks dealmaking; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up […]

Los Angeles Biotech News

GSK’s ViiV Healthcare set to launch second season of LGBTQ+ Latinx ‘telenovela-style’ podcast with celeb voices

GSK’s ViiV is returning with a second season of its award-winning podcast “Love in Gravity.” This time, instead of a different relationship story each week, the LGBTQ+ series will focus on one story across seven […]

Los Angeles Biotech News

U.S. HOUSE OF REPRESENTATIVES SUPPORTS $20 MILLION FOR PANCREATIC CANCER RESEARCH FUNDING

With Leadership from Pancreatic Cancer Action Network (PanCAN) Champions in Congress, House Defense Appropriations Bill Passes with Increase to Pancreatic Cancer Research Program at Department of Defense LOS ANGELES, Sept. 29, 2023 /PRNewswire/ — The […]

No Picture
Los Angeles Biotech News

Innovative Health Diagnostics Debuts New LabFlow Platform to Enhance At-Home Testing Capabilities for Digital Health Companies

Part of IHDLab’s Diagnostics-as-a-Service Offering, LabFlow Seamlessly Integrates with Companies’ Existing Digital Infrastructures to Provide Over 85 Validated At-Home Lab Tests IRVINE, Calif., Sept. 29, 2023 /PRNewswire/ — Innovative Health Diagnostics (“IHDLab” or the “Company”), […]

Los Angeles Biotech News

GEDi Cube and Renovaro Biosciences Sign Definitive Agreement to Combine

LOS ANGELES & AMSTERDAM–(BUSINESS WIRE)–GEDi Cube Intl Ltd. (GEDi Cube), an AI medical technology company, and Renovaro Biosciences Inc. (NASDAQ:RENB) (Renovaro), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy, have signed a definitive […]

Los Angeles Biotech News

Alexandria Real Estate Equities, Inc.’s Strong BBB+ Credit Rating With Positive Outlook Reaffirmed by S&P Global Ratings

Alexandria’s investment-grade credit ratings, which rank in the top 10% among all publicly traded U.S. REITs, and significant liquidity of $6.3 billion afford the company important flexibility to execute its differentiated life science real estate […]

Los Angeles Biotech News

Exclusive: Former Genentech duo reunites to push Sonoma into the clinic; Ex-Magenta commercial chief heads to Editas

Joe Arron and Mark Eisner worked together for about a decade at Genentech, with broad remits but a shared passion for interstitial lung disease. They’d go their separate ways a few years ago — Arron […]